According to Celldex Therapeutics's latest financial reports the company's current earnings are $7.55 Million USD. In 2024 the company made an earning of -$0.2 Billion USD a decrease over its 2023 earnings that were of -$0.15 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | -$0.22 Billion | 11.34% |
2024 | -$0.2 Billion | 37.34% |
2023 | -$0.15 Billion | 32.63% |
2022 | -$0.11 Billion | 54.88% |
2021 | -$69.15 Million | 39.49% |
2020 | -$49.58 Million | -9.08% |
2019 | -$54.53 Million | -28.64% |
2018 | -$76.41 Million | -30.11% |
2017 | -$0.11 Billion | -17.75% |
2016 | -$0.14 Billion | 4.5% |
2015 | -$0.13 Billion | 4.09% |
2014 | -$0.13 Billion | 51.57% |
2013 | -$80.63 Million | 40.1% |
2012 | -$57.55 Million | |
2010 | -$1.25 Million | -96.59% |
2009 | -$36.61 Million | |
2006 | -$22.37 Million | |
2004 | -$13.59 Million | 15.75% |
2003 | -$11.74 Million | -18.69% |
2002 | -$14.44 Million | -41.22% |
2001 | -$24.56 Million | 59% |
2000 | -$15.45 Million | 27.65% |
1999 | -$12.1 Million | 53.12% |
1998 | -$7.9 Million | 2.6% |
1997 | -$7.7 Million | -33.62% |
1996 | -$11.6 Million |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Seagen
SGEN | -$0.8 Billion | 263.97% | ๐บ๐ธ USA |
![]() Agenus
AGEN | -$94.24 Million | -56.62% | ๐บ๐ธ USA |
![]() Emergent BioSolutions
EBS | -$0.9 Million | -99.59% | ๐บ๐ธ USA |
![]() Amgen AMGN | $6.65 B | -3,161.57% | ๐บ๐ธ USA |
![]() Pfizer PFE | $10.34 B | -4,860.85% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $5.41 B | -2,591.20% | ๐ฌ๐ง UK |
![]() Titan Pharmaceuticals
TTNP | -$4.21 Million | -98.06% | ๐บ๐ธ USA |